Ru Yang
Direktor/Vorstandsmitglied bei SHENZHEN KINGSUN SCIENCE & TECHNOLOGY CO.,LTD
Profil
Ru Yang is currently working as an Independent Director at Xiamen Zeesan Biotech Co., Ltd.
and Shenzhen Kingsun Science & Technology Co., Ltd.
Prior to this, Ms. Yang graduated from Southwest University of Political & Law in 2009.
Aktive Positionen von Ru Yang
| Unternehmen | Position | Beginn |
|---|---|---|
| SHENZHEN KINGSUN SCIENCE & TECHNOLOGY CO.,LTD | Direktor/Vorstandsmitglied | 01.08.2021 |
Xiamen Zeesan Biotech Co., Ltd.
 Xiamen Zeesan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Xiamen Zeesan Biotech Co., Ltd. engages in the research and development, production, and sales of molecular diagnostic technology, molecular diagnostic reagents, and molecular diagnostic instruments. It specializes in molecular diagnostic reagent products and molecular diagnostic instrument products, provides the basis for disease screening and diagnosis, drug selection and efficacy monitoring of infectious diseases including respiratory disease and human papillomavirus infection, hematologic oncology, personalized medicine and genetic diseases. The company was founded on June 12, 2010 and is headquartered in Xiamen, China. | Direktor/Vorstandsmitglied | 23.08.2021 |
Ausbildung von Ru Yang
| Southwest University of Political & Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SHENZHEN KINGSUN SCIENCE & TECHNOLOGY CO.,LTD | Technology Services |
| Private Unternehmen | 1 |
|---|---|
Xiamen Zeesan Biotech Co., Ltd.
Xiamen Zeesan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Xiamen Zeesan Biotech Co., Ltd. engages in the research and development, production, and sales of molecular diagnostic technology, molecular diagnostic reagents, and molecular diagnostic instruments. It specializes in molecular diagnostic reagent products and molecular diagnostic instrument products, provides the basis for disease screening and diagnosis, drug selection and efficacy monitoring of infectious diseases including respiratory disease and human papillomavirus infection, hematologic oncology, personalized medicine and genetic diseases. The company was founded on June 12, 2010 and is headquartered in Xiamen, China. | Health Services |
